Praluent Has Seen Great Efficacy With LDL: Edelberg

Sanofi Vice President of Strategic Development & Launch Unit, Dr. Jay Edelberg, discusses the latest drug from Sanofi that recently received partial backing from FDA advisers and the possible impact the drug can make. He speaks with Stephanie Ruhle and Erik Schatzker on Bloomberg Television's “Market Makers.” (Source: Bloomberg)

Infosys CEO Resigns After Criticism From Founders
01:37 - Infosys Ltd. Chief Executive Officer Vishal Sikka has stepped down following criticism from the company’s founder. Chief Operating Officer Pravin Rao will become interim CEO. Bloomberg's Caroline Hyde reports on "Bloomberg Technology." (Source: Bloomberg)
  • Essential's 360 Degree Approach to Smartphones
  • Why Industrial Metals May Be in a Bull Market
  • Who Moved the Most on Bloomberg's Billionaire Index 8/18